Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

The potential of exosomes from adipose-derived stromal-vascular fraction in Increasing Migration Activity of Human Dental Pulp Stromal Cells (in vitro study ).

Alinda SD., Margono A., Yulianto I., Maharti ID., Rafmawan RA.

Laboratory Study on Chronic Wound, published in Saudi Dent J (2024) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Saudi Dent J (2024)
Country
Saudi Arabia
Reported sample size
—
Source database
PubMed
PMID
39619718
PMCID
PMC11605707
DOI
10.1016/j.sdentj.2024.08.005
Citations
2

Abstract (original English)

Migration of dental pulp stromal cells (DPSCs) significantly responds to wound healing after pulp injury. Deriving from low compliance characteristics, pulp tissue regeneration is challenging and depends on the microenvironmental signals. Exosomes can maintain and carry bioactive proteins that are crucial in cell communication. Adipose tissue-derived stromal vascular fraction (AD-SVF), a heterogeneous group of progenitor cells, is a promising source of exosomes. Discover the impact of exosomes derived from an adipose-derived stromal-vascular fraction (AD-SVF Exo) on human dental pulp stromal cells (hDPSCs) migration. Methods: In-vitro design involving AD-SVF Exo applied to hDPSCs cultivated until 80% confluence and 3rd-4th passage. AD-SVF Exo isolation through size exclusion chromatography (SEC). The AD-SVF Exo was characterized using Nanoparticle Tracking Analysis (NTA) and flow cytometry assays. hDPSCs were exposed to AD-SVF Exo (0% as the control group, 0.1%, and 1% as the experimental group), subjected to a scratch wound assay, and observed at 6, 24, and 48 h. hDPSCs cultured expressed mesenchymal stem cell mesenchymal stem cell (MSC) markers and formed loose colonies with characteristic spindle-shaped morphology. AD-SVF Exo consisted of marker proteins CD9 and CD63, and NTA measurement demonstrated a diameter of 103 ± 24 nm in diameter with 1,6 x 10 8 particles/ml. Based o

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research